Media coverage
1
Media coverage
Title Aeglea BioTherapeutics Announces New Positive Phase 1/2 Data for Pegzilarginase in Patients with Arginase 1 Deficiency at 2019 Annual Meeting of the Society for Inherited Metabolic Disorders Media name/outlet PredictWallStreet Country/Territory United States Date 7/04/19 URL https://predictwallstreet.com/News/Story.aspx?StoryID=36647df48132251e Persons George Diaz